Rawa Kamaran Ismail

4PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Recommender systemsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 09, 2022
End-of-Life Use of Systemic Therapy in Patients With Advanced Melanoma: A Nationwide Cohort Study.

Jesper van Breeschoten, Rawa K Ismail, Michel W J M Wouters

|Jun 23, 2022
Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis.

Rawa Kamaran Ismail, Jesper van Breeschoten, Silvia van der Flier

|Oct 04, 2021
The unfavorable effects of COVID-19 on Dutch advanced melanoma care.

Olivier J van Not, Jesper van Breeschoten, Alfonsus J M van den Eertwegh

|Jun 20, 2020
Real-world outcomes of advanced melanoma patients not represented in phase III trials.

Michiel C T van Zeijl, Rawa K Ismail, Liesbeth C de Wreede

Pageof 1